FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.6486
+0.0116 (1.82%)
At close: Aug 1, 2025, 4:00 PM
0.6420
-0.0066 (-1.02%)
After-hours: Aug 1, 2025, 7:24 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $25.45 million as of August 1, 2025. Its market cap has decreased by -86.78% in one year.
Market Cap
25.45M
Enterprise Value
27.38M
1-Year Change
-86.78%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $25.45M, a decrease of -97.31%. That is a compound annual growth rate of -91.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 25.45M | -63.73% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.55B |
| Novo Nordisk | 213.92B |